Machine Learning in Biotech
Luis discusses the innovative combination of single cell genomics and machine learning, emphasizing the ability to profile individual cells for a deeper understanding of biological heterogeneity. He shares insights into the founding of the company, highlighting the unique perspective brought by founders without traditional biology backgrounds and the collaboration with scientific experts to shape the company's vision.In this clip
From this podcast
The AI Podcast
Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
Related Questions